GlassScriptPhysician profile
Colleen Atchley
NPI 1578810487
$2,623.71
in general payments reported to CMS, 2019-2025
13 companies · $931 in 2025
The $931 reported for 2025 was more than what 79% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $145 · 2022: $241 · 2023: $721 · 2024: $586 · 2025: $931.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,237.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $832.95 | 2021-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $560.69 | 2021-2025 | Caplyta |
| Axsome Therapeutics, INC. | $391.64 | 2024-2025 | Auvelity |
| Alkermes, INC. | $261.24 | 2023-2025 | Aristada, Lybalvi, Aristada Initio |
| E.R. Squibb & Sons, L.L.C. | $124.97 | 2025 | Cobenfy |
| Neurocrine Biosciences, INC. | $124.97 | 2023 | Ingrezza |
| Vanda Pharmaceuticals INC. | $124.95 | 2025 | Fanapt |
| Vertex Pharmaceuticals Incorporated | $102.92 | 2025 | |
| Paratek Pharmaceuticals, INC. | $31.11 | 2025 | Nuzyra |
| Lundbeck LLC | $22.83 | 2025 | Rexulti |
| Verona Pharma, INC. | $17.76 | 2025 | Ohtuvayre |
| Exact Sciences Corporation | $16.26 | 2023 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $11.42 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Colleen Atchley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.